Oppenheimer Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,098
| Closed | -$307K | – | 1158 |
|
|
2025
Q2 | $307K | Buy |
1,098
+212
| +24% | +$60.1K | ﹤0.01% | 984 |
|
|
2025
Q1 | $276K | Buy |
+886
| New | +$262K | ﹤0.01% | 984 |
|
|
2024
Q4 | – | Sell |
-5,099
| Closed | -$1.64M | – | 1153 |
|
|
2024
Q3 | $1.64M | Sell |
5,099
-758
| -13% | -$248K | 0.02% | 598 |
|
|
2024
Q2 | $1.83M | Sell |
5,857
-7,164
| -55% | -$2.1M | 0.02% | 548 |
|
|
2024
Q1 | $3.7M | Sell |
13,021
-1,622
| -11% | -$475K | 0.05% | 343 |
|
|
2023
Q4 | $4.22M | Sell |
14,643
-1,937
| -12% | -$528K | 0.06% | 332 |
|
|
2023
Q3 | $4.46M | Buy |
16,580
+332
| +2% | +$82.9K | 0.07% | 309 |
|
|
2023
Q2 | $3.61M | Sell |
16,248
-89
| -0.5% | -$20.7K | 0.05% | 363 |
|
|
2023
Q1 | $3.95M | Buy |
16,337
+981
| +6% | +$241K | 0.06% | 321 |
|
|
2022
Q4 | $4.03M | Buy |
15,356
+433
| +3% | +$116K | 0.06% | 314 |
|
|
2022
Q3 | $3.36M | Buy |
14,923
+2,084
| +16% | +$505K | 0.06% | 321 |
|
|
2022
Q2 | $3.12M | Buy |
12,839
+899
| +8% | +$220K | 0.05% | 359 |
|
|
2022
Q1 | $2.89M | Buy |
11,940
+1,150
| +11% | +$264K | 0.04% | 424 |
|
|
2021
Q4 | $2.43M | Sell |
10,790
-1,516
| -12% | -$320K | 0.03% | 493 |
|
|
2021
Q3 | $2.62M | Sell |
12,306
-8,220
| -40% | -$1.89M | 0.04% | 449 |
|
|
2021
Q2 | $5M | Buy |
20,526
+773
| +4% | +$190K | 0.07% | 301 |
|
|
2021
Q1 | $4.92M | Buy |
19,753
+1,842
| +10% | +$440K | 0.08% | 296 |
|
|
2020
Q4 | $4.12M | Sell |
17,911
-26,531
| -60% | -$6.12M | 0.07% | 313 |
|
|
2020
Q3 | $11.3M | Sell |
44,442
-2,389
| -5% | -$592K | 0.22% | 116 |
|
|
2020
Q2 | $11M | Buy |
46,831
+350
| +0.8% | +$79.9K | 0.23% | 110 |
|
|
2020
Q1 | $9.42M | Buy |
46,481
+12,278
| +36% | +$2.68M | 0.23% | 110 |
|
|
2019
Q4 | $8.25M | Buy |
34,203
+585
| +2% | +$129K | 0.17% | 150 |
|
|
2019
Q3 | $6.5M | Sell |
33,618
-714
| -2% | -$137K | 0.14% | 175 |
|
|
2019
Q2 | $6.33M | Sell |
34,332
-8,704
| -20% | -$1.56M | 0.14% | 187 |
|
|
2019
Q1 | $8.18M | Sell |
43,036
-755
| -2% | -$144K | 0.18% | 138 |
|
|
2018
Q4 | $8.53M | Buy |
43,791
+3,150
| +8% | +$615K | 0.21% | 110 |
|
|
2018
Q3 | $8.42M | Sell |
40,641
-665
| -2% | -$131K | 0.19% | 137 |
|
|
2018
Q2 | $7.63M | Buy |
41,306
+645
| +2% | +$114K | 0.19% | 139 |
|
|
2018
Q1 | $6.93M | Buy |
40,661
+2,246
| +6% | +$412K | 0.17% | 148 |
|
|
2017
Q4 | $7.16M | Hold |
38,415
| – | – | 0.19% | 135 |
|
|
2017
Q3 | $7.16M | Buy |
38,415
+183
| +0.5% | +$32.4K | 0.19% | 137 |
|
|
2017
Q2 | $6.58M | Buy |
38,232
+702
| +2% | +$114K | 0.18% | 141 |
|
|
2017
Q1 | $6.16M | Buy |
+37,530
| New | +$6.24M | 0.18% | 142 |
|
Other funds holding AMGN
Oppenheimer Asset Management's AMGN Position: Q3 2025 in Review
Oppenheimer Asset Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,098 shares — an estimated $307K sold.
Oppenheimer Asset Management first reported a position in AMGN in Q1 2017 and held it in 33 quarters. The position peaked at $11.3M in Q3 2020. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Oppenheimer Asset Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Oppenheimer Asset Management sold 1,098 Amgen shares in Q3 2025, an estimated $307K.
- Oppenheimer Asset Management first reported a position in Amgen in Q1 2017 and held it in 33 quarters.
- Oppenheimer Asset Management's Amgen position peaked at $11.3M in Q3 2020.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Oppenheimer Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.